Development and fairness assessment of machine learning models for predicting 30-day readmission after lung cancer surgery.
Atulya Aman Khosla(Baptist Hospital of Miami), Ishmael Jaiyesimi(Beaumont Hospital, Royal Oak), Akshit Chitkara(Thomas Jefferson University), Manas Pustake(Texas Tech University), Yanjia Zhang(Kunming University of Science and Technology), Rohit Singh(University of Vermont Medical Center), Nitya Batra(Jacksonville College), Sonal Yadav(Baptist Health South Florida), Anshul Saxena(Baptist Hospital of Miami), Yagnapriya Ammakola(Beaumont Hospital, Troy), Karan Jatwani(Roswell Park Comprehensive Cancer Center), Gilbert Revoredo(Baptist Health South Florida), Mohammad Arfat Ganiyani(Baptist Hospital of Miami)
Cited by 0
Related Papers
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|125
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|116
Early Detection of Subclinical Visual Damage After Blast-Mediated TBI Enables Prevention of Chronic Visual Deficit by Treatment With P7C3-S243
|Investigative Ophthalmology & Visual Science|2014|91
Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention
|Tropical parasitology|2016|80
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.1
|Journal of Clinical Oncology|2023|51